1. Aboujaoude E, Barry JJ, Gamel N (2009) Memantine augmentation in treatment-resistant obsessive–compulsive disorder: an open-label trial. J Clin Psychopharmacol 29:51–55
2. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington
3. Aouizerate B, Guehl D, Cuny E, Rougier A, Burbaud P, Tignol J, Bioulac B (2005) Updated overview of the putative role of the serotoninergic system in obsessive–compulsive disorder. Neuropsychiatr Dis Treat 1:231–243
4. Arnold PD, Rosenberg DR, Mundo E, Tharmalingam S, Kennedy JL, Richter MA (2004) Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study. Psychopharmacology (Berl) 174:530–538
5. Baxter LR (1999) Functional imaging of brain systems mediating obsessive–compulsive disorder. In: Bunney CENW (ed) Neurobiology of Mental Illness. Oxford University Press, New York, pp 534–547